Stock A068760 CELLTRION PHARM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Celltrion Pharm, Inc.

Equities

A068760

KR7068760008

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
92,900 KRW +2.99% Intraday chart for Celltrion Pharm, Inc. -0.21% +0.76%
16/01 Celltrion Holdings Actively Pursuing Nasdaq Listing MT
02/01 Celltrion's Shares Climb After Merger With Affiliate DJ

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Celltrion Holdings Actively Pursuing Nasdaq Listing
MT
Celltrion's Shares Climb After Merger With Affiliate
DJ
S.Korean shares end slightly higher as chipmakers advance; US CPI in focus
RE
South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil
MT
Celltrion Discloses Merger Plans with Celltrion HealthCare; Celltrion Shares Jump 5%
MT
Exclusive-Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources
RE
South Korean Stocks Rise on Gains by Batterymakers; Samsung SDI Stock Rises 2%
MT
Celltrion Group Creator Expected to Resume Leadership Role
MT
Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill
DJ
Celltrion : South Korea approves Celltrion's COVID-19 treatment for use
RE
Samsung Electronics : S.Korea shares dip as surging global coronavirus cases dent sentiment
RE
Celltrion : South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation
RE
Celltrion Pharm : S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation
RE
Samsung Electronics : S.Korea shares jump most in two weeks on falling virus cases, upbeat China data
RE
Celltrion : South Korea's Celltrion to merge with affiliates to set up holding company structure
RE
Celltrion Pharm, Inc.(KOSDAQ:A068760) added to FTSE All-World Index
CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2017
CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2016
CI
Teva Pharmaceutical May Buy Celltrion
CI
Celltrion Pharm Inc. Reports Earnings Results for the Quarter and Period Ended June 30, 2016
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A068760 Stock
  4. News Celltrion Pharm, Inc.